Detection of microparticles from human red blood cells by multiparametric flow cytometry

Blood Transfusion

Volumn 13, Issue 2, 2015, Pages 274-280

  Grisendi, Giulia ^a   Finetti, Elena ^b   Manganaro, Daniele ^c   Cordova, Nicoletta ^a   Montagnani, Giuliano ^a   Spano, Carlotta ^a   Prapa, Malvina ^a   Guarneri, Valentina ^d   Otsuru, Satoru ^e   Horwitz, Edwin M ^e,f   Mari, Giorgio ^b   Dominici, Massimo ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b R and D Filter Department Fresenius HemoCare Italy   (Italy)

^c TelecomItalia Finsiel Group   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e Department of Medical and Surgical Neonatology   (Italy)

^f NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

CFSE; Flow cytometry; Microparticles; Red blood cells

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GLYCOPHORIN A; LIPOCORTIN 5;

ARTICLE; BLOOD BANK; BLOOD CELL; BLOOD TRANSFUSION; ERYTHROCYTE; FLOW CYTOMETRY; HEMOLYSIS; HUMAN; LIGHT SCATTERING; MEMBRANE STRUCTURE; PATHOGENESIS; QUALITY CONTROL; TRANSFUSION MEDICINE; BLOOD STORAGE; CONTROLLED STUDY; FEMALE; MALE; MEMBRANE MICROPARTICLE; METABOLISM; RANDOMIZED CONTROLLED TRIAL; TIME FACTOR;

BLOOD PRESERVATION; CELL-DERIVED MICROPARTICLES; ERYTHROCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; TIME FACTORS;

EID: 84927539091     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2014.0136-14     Document Type: Article

References (44)

1. Vincent JL, Baron JF, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-507.
2. Corwin HL, Gettinger A, Pearl RG, et al. The CRIT study: anemia and blood transfusion in the critically ill: current clinical practice in the United States. Crit Care Med 2004;32:39-52.
3. Napolitano LM, Kurek S, Luchette FA, et al. American College of Critical Care Medicine of the Society of Critical Care Medicine, Eastern Association for the Surgery of Trauma Practice Management Workgroup. Clinical practice guideline: red blood cell transfusion in adult trauma and critical care. Crit Care Med 2009;37:3124-57.
4. Spiess BD. Risks of transfusion: outcome focus. Transfusion 2004;44(12 Suppl):4S-14S.
5. Edgren G, Kamper-Jorgensen M, Eloranta S, et al. Duration of red blood cell storage and survival of transfused patients. Transfusion 2010;50:1185-95.
6. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229-39.
7. Hess JR. Red cell changes during storage. Transfus Apher Sci 2010;43:51-9.
8. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007;104:17063-8.
9. Greenwalt TJ. The how and why of exocytic vesicles. Transfusion 2006;46:143-52.
10. Bosman GJ, Lasonder E, Luten M, et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 2008;48:827-35.
11. Mause SF, Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circulation Res 2010;107:1047-57.
12. Hargett LA, Bauer NN. On the origin of microparticles: from "platelet dust" to mediators of intercellular communication. Pulm Circ 2013;3:329-40.
13. Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol 1967;13:269-88.
14. Ogata N, Nomura S, Shouzu A, et al. Elevation of monocytederived microparticles in patients with diabetic retinopathy. Diabetes Res Clin Pract 2006;73:241-8.
15. Piccin A, Murphy WG, Smith OP. Circulating microparticles: pathophysiology and clinical implications. Blood Rev 2007;21:157-71.
16. Soriano AO, Jy W, Chirinos JA, et al. Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis. Crit Care Med 2005;33:2540-6.
17. Van Wijk MJ, Van Bavel E, Sturk A, Nieuwland R. Microparticles in cardiovascular diseases. Cardiovasc Res 2003;59:277-87.
18. Mantel PY, Hoang AN, Goldowitz I, et al. Malariainfected erythrocyte-derived microvesicles mediate cellular communication within the parasite population and with the host immune system. Cell Host Microbe 2013;13:521-34.
19. Ramakrishnaiah V, Thumann C, Fofana I, et al. Exosomemediated transmission of hepatitis C virus between human hepatoma Huh7.5 cells. Proc Natl Acad Sci USA 2013;110:13109-13.
20. Regev-Rudzki N, Wilson DW, Carvalho TG, et al. Cell-cell communication between malaria-infected red blood cells via exosome-like vesicles. Cell 2013;153:1120-33.
21. Rubin O, Canellini G, Delobel J, et al. Red blood cell microparticles: clinical relevance. Transfus Med Hemother 2012;39:342-7.
22. Tissot JD, Rubin O, Canellini G. Analysis and clinical relevance of microparticles from red blood cells. Curr Opin Hematol 2010;17:571-7.
23. Simak J, Gelderman MP. Cell membrane microparticles in blood and blood products: potentially pathogenic agents and diagnostic markers. Transfus Med Rev 2006;20:1-26.
24. Ayers L, Kohler M, Harrison P, et al. Measurement of circulating cell-derived microparticles by flow cytometry: sources of variability within the assay. Thromb Res 2011;127:370-7.
25. Van der Vlist EJ, Nolte-'t Hoen EN, Stoorvogel W, et al. Fluorescent labeling of nano-sized vesicles released by cells and subsequent quantitative and qualitative analysis by highresolution flow cytometry. Nature Protocols 2012;7:1311-26.
26. Rubin O, Crettaz D, Canellini G, et al. Microparticles in stored red blood cells: an approach using flow cytometry and proteomic tools. Vox Sang 2008;95:288-97.
27. Xiong Z, Cavaretta J, Qu L, et al. Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion 2011;51:610-21.
28. Xiong Z, Oriss TB, Cavaretta JP, et al. Red cell microparticle enumeration: validation of a flow cytometric approach. Vox Sang 2012;103:42-8.
29. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger CJ. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V. A novel assay for apoptosis. Immunol Methods 1995;184:39-51.
30. Gkoumassi E, Dijkstra-Tiekstra MJ, Hoentjen D, de Wildt-Eggen J. Hemolysis of red blood cells during processing and storage. Transfusion 2012;52:489-92.
31. Parish CR, Warren HS. Use of the intracellular fluorescent dye CFSE to monitor lymphocyte migration and proliferation. Curr Protoc Immunol 2002; Chapter 4: Unit 4.9.
32. Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007;2:2049-56.
33. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005;23:69-74.
34. Parish CR. Fluorescent dyes for lymphocyte migration and proliferation studies. Immunol Cell Biol 1999;77:449-508.
35. Lee JS, Gladwin MT. Bad blood: the risks of red cell storage. Nat Med 2010;16:381-2.
36. Sowemimo-Coker SO. Red blood cell hemolysis during processing. Transfusion Med Rev 2002;16:46-60.
37. Nantakomol D, Imwong M, Soontarawirat I, et al. The absolute counting of red cell derived microparticles with red cell bead by flow rate based assay. Cytometry B Clin Cytom 2009;76:191-8.
38. Aras O, Shet A, Bach RR, et al. Induction of microparticle and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004;103:4545-53.
39. Connor DE, Exner T, Ma DD, Joseph JE. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb Haemostasis 2010;103:1044-52.
40. Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003;102:2678-83.
41. Rubin O, Crettaz D, Tissot JD, Lion N. Microparticles in stored red blood cells: submicron clotting bombs? Blood Transfus 2010;8:31-8.
42. Last'ovicka J, Budinsky V, Spisek R, Bartnkova J. Assessment of lymphocyte proliferation: CFSE kills dividing cells and modulates expression of activation markers. Cell Immunol 2009;256:79-85.
43. Jordan MB, van Rooijen N, Izui S, et al. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood 2003;101:594-601.
44. Donadee C, Raat NJ, Kanias T, et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 2011;124:465-76.